Patient-derived, genome-edited and environmentally induced disease models
Work with your own iPSC lines, our proprietary lines, or leverage our sourcing and reprogramming services.
If required, you can benefit from highly efficient genome editing for your iPSC line of choice with our proprietary STAR CRISPR technology.
To maximize reproducibility, cells are differentiated at the scale and volume you need with a rigorously characterized for identity and functionality.
Innovate, de-risk and enhance translational success
Our expertise in iPSC technology and profound understanding of its applications enable our team to develop everything from pilot and validation studies to full screening campaigns.
We offer a multitude of cell models, technologies and readouts that can be combined and applied to any therapeutic modality.
- Monoculture, co-culture and triculture models
- 2D or 3D formats
- Low to high throughput
- Multiplexing
Achieve a high-throughput format with robust and reproducible results
Integrating iPSC-based assays in large screening campaigns doesn't have to be a challenge anymore.
Our team has the capabilities and expertise to miniaturize - reducing costs - and automate relevant cell-based assays while keeping a strong focus on delivering high-quality and reproducible data.
Biotech Company,Senior Scientist
Pharma Company, Boston Area,Scientist
Large Pharma Company,Project Manager
Incorporate relevant cell models
in your drug discovery pipeline
We’re ready to help make your next step the very best it can be. So let’s start with a conversation – about your vision, goals and expectations for your drug discovery projects.
